Michael Lewis

Cheyne Capital Management (UK) LLP (Cheyne) is the alternative investment fund management subsidiary of Cheyne Capital Management Ltd., ultimately held by Novatrust Ltd. in Great Britain. The firm was founded by Jonathan Lourie and Stuart Fiertz in 2000. Headquartered in London, Cheyne manages the Cheyne Funds for a range of clients which include pension funds, insurance companies, sovereign wealth funds, endowments, banks, funds of funds and other financial institutions as well as family offices and high net-worth individuals.

Histogenics Corp. engages in the development, marketing, and commercialization of restorative cell therapies. Its regenerative medicine platform combines expertise in cell processing, scaffolding, tissue engineering, bioadhesives, and growth factors to provide solutions that can be utilized individually and in concert to treat musculoskeletal-related conditions. The company was founded on June 28, 2000 and is headquartered in Waltham, MA.

Axel Springer SE engages in the provision of print and digital media and owns and operates digital classifieds portfolio. It operates through the following segments: Classified Ad Models, Paid Models, Marketing Models and Services/Holding. The Classified Ad Models segment generates revenues in online classified advertising within the areas of jobs, real estate, automobile and general classified ads. The Paid Models segment encompasses all business models that are used by paying readers. The Marketing Models segment covers all business models involving sales to advertising customers under reach-based or success-based marketing services. The Services/Holding segment comprises the group's services, which include the domestic printing plants and the holding company functions. The company was founded by Hinrich Springer and Axel Springer in 1946 and is headquartered in Berlin, Germany.

ProChon Biotech, Ltd. manufactures innovative growth factor-based therapies in regenerative medicine and orthopedics. The company was founded by Avner Yayon in 1995 and is headquartered in Tel Aviv, Israel.

Part of Colmar Investment Holdings Ltd., Oceana Investment Corp. Ltd. operates as a British investment company. The private company is based in London, UK.